Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium-Reference-Cited by-同舟云学术

Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium

Published:2012-05-17 Issue:7 Volume:103 Page:1334-1341
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Pils Dietmar¹,Hager Gudrun¹,Tong Dan¹,Aust Stefanie¹,Heinze Georg²,Kohl Maria²,Schuster Eva¹,Wolf Andrea¹,Sehouli Jalid³,Braicu Ioana³,Vergote Ignace⁴,Cadron Isabelle⁴,Mahner Sven⁵,Hofstetter Gerda⁶,Speiser Paul¹,Zeillinger Robert

Affiliation:

1. Molecular Oncology Group; Department of Obstetrics and Gynecology; Medical University of Vienna; Vienna

2. Section for Clinical Biometrics; Center for Medical Statistics, Informatics and Intelligent Systems; Medical University of Vienna; Vienna; Austria

3. Department of Gynecology; Campus Virchow Klinikum; Charite Medical University; Berlin; Germany

4. Division of Gynecological Oncology; Department of Obstetrics and Gynecology and Leuven Cancer Institute; University Hospitals Leuven; Katholieke Universiteit Leuven; Leuven; Belgium

5. Department of Gynecology and Gynecologic Oncology; University Medical Center Hamburg-Eppendorf; Hamburg; Germany

6. Department of Gynecology and Obstetrics; Medical University Innsbruck; Innsbruck

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2012.02306.x/fullpdf

Reference28 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. A molecular signature for epithelial to mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis;Joyce;Clin Exp Metastasis,2009

3. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer;Glinsky;J Clin Invest,2005